141 related articles for article (PubMed ID: 9225292)
1. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.
Lummis SC; Baker J
Neuropharmacology; 1997; 36(4-5):665-70. PubMed ID: 9225292
[TBL] [Abstract][Full Text] [Related]
2. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.
Molderings GJ; Schmidt K; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):245-52. PubMed ID: 8878053
[TBL] [Abstract][Full Text] [Related]
5. Chlorpromazine and QX222 block 5-HT3 receptors in N1E-115 neuroblastoma cells.
Sepúlveda MI; Baker J; Lummis SC
Neuropharmacology; 1994; 33(3-4):493-9. PubMed ID: 7984288
[TBL] [Abstract][Full Text] [Related]
6. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
7. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vanderheijden PM; Vijverberg HP
Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
Boess FG; Sepúlveda MI; Lummis SC; Martin IL
Neuropharmacology; 1992 Jun; 31(6):561-4. PubMed ID: 1407396
[TBL] [Abstract][Full Text] [Related]
9. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors.
Cubeddu LX; Bönisch H; Göthert M; Molderings G; Racké K; Ramadori G; Miller KJ; Schwörer H
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):85-91. PubMed ID: 10651152
[TBL] [Abstract][Full Text] [Related]
12. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
13. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
14. Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930.
Hoyer D; Neijt HC; Karpf A
J Recept Res; 1989; 9(1):65-79. PubMed ID: 2915346
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
Ito C; Isobe Y; Tsuchida K; Higuchi S
Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
[TBL] [Abstract][Full Text] [Related]
16. Ethanol fails to modify [3H]GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranes.
Hellevuo K; Hoffman PL; Tabakoff B
Alcohol Clin Exp Res; 1991 Oct; 15(5):775-8. PubMed ID: 1755508
[TBL] [Abstract][Full Text] [Related]
17. Effects of detergents on binding of 5-hydroxytryptamine3 receptor antagonist [3H]GR65630 to rat cortical membranes.
Inoue A; Tominaga Y; Nishio H; Segawa T; Nakata Y
Neurochem Int; 1993 Jun; 22(6):547-53. PubMed ID: 8513282
[TBL] [Abstract][Full Text] [Related]
18. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells.
Lummis SC; Kilpatrick GJ; Martin IL
Eur J Pharmacol; 1990 Sep; 189(2-3):223-7. PubMed ID: 2253704
[TBL] [Abstract][Full Text] [Related]
20. Allosteric interactions among agonists and antagonists at 5-hydroxytryptamine3 receptors.
Bonhaus DW; Stefanich E; Loury DN; Hsu SA; Eglen RM; Wong EH
J Neurochem; 1995 Jul; 65(1):104-10. PubMed ID: 7790853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
